IART - Integra LifeSciences Holdings Corporation
| Previous Close | 66.62 |
| Open | 66.65 |
| Bid | 66.54 x 800 |
| Ask | 66.56 x 2200 |
| Day's Range | 66.29 - 66.93 |
| 52 Week Range | 41.51 - 67.50 |
| Volume | 366,743 |
| Avg. Volume | 823,462 |
| Market Cap | 5.665B |
| Beta | 0.65 |
| PE Ratio (TTM) | 75.91 |
| EPS (TTM) | 0.88 |
| Earnings Date | Jul 24, 2018 - Jul 30, 2018 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 63.09 |
Markit•12 days agoSee what the IHS Markit Score report has to say about Integra Lifesciences Holdings Corp.
Integra Lifesciences Holdings Corp NASDAQ/NGS:IART
- PR Newswire•20 days ago
Evergy Set to Join S&P 500; Navient and Integra Lifesciences Holdings to Join S&P MidCap 400; Ambac Financial Group to Join S&P SmallCap 600
NEW YORK , May 31, 2018 /PRNewswire/ -- S&P Midcap 400 constituent Westar Energy Inc. (NYSE: WR), to be renamed Evergy, will replace Navient Corp. (NASD: NAVI) in the S&P 500, Navient will replace Westar ...
- Zacks•26 days ago
Why Is Integra LifeSciences (IART) Up 8.5% Since Its Last Earnings Report?
Integra LifeSciences (IART) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- GlobeNewswire•28 days ago
Integra LifeSciences to Present at Healthcare Conferences in June 2018
PLAINSBORO, N.J., May 23, 2018-- Integra LifeSciences Holdings Corporation, a leading global medical technology company, will present at the following healthcare conferences in June:. On Wednesday, June ...
- GlobeNewswire•last month
Analysis: Positioning to Benefit within Webster Financial, Integra LifeSciences, OSI, Tivity Health, LCI Industries, and TrueCar — Research Highlights Growth, Revenue, and Consolidated Results
NEW YORK, May 17, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Webster ...
- ACCESSWIRE•last month
Free Post Earnings Research Report: Integra’s Quarterly Sales Surged 38%; Adjusted EPS Soared 49%
LONDON, UK / ACCESSWIRE / May 16, 2018 / If you want access to our free earnings report on Integra LifeSciences Holdings Corp. (NASDAQ: IART) ("Integra"), all you need to do is sign up now by clicking the following link www.active-investors.com/registration-sg/?symbol=IART. The Company reported its first quarter fiscal 2018 operating and financial results on April 25, 2018. Additionally, the Company raised its revenue and earnings guidance for FY18.
- Benzinga•last month
Benzinga's Daily Biotech Pulse: ARMO Skyrockets On Eli Lilly Deal, Akcea Meets FDA Panel, vTv Alzheimer's Trial Results
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Stocks hitting 52-week highs on May 9) ABIOMED, Inc. (NASDAQ: ABMD ) Adaptimmune Therapeutics PLC – ...
- GlobeNewswire•last month
Integra LifeSciences Prices Public Offering of Common Stock
Integra LifeSciences Holdings Corporation (IART), a leading global medical technology company, today announced that it has priced its previously announced underwritten public offering of 5,250,000 shares of its common stock at $58.50 per share. In connection with this offering, Integra has also granted the underwriters a 30-day option to purchase an additional 787,500 shares of common stock. The offering is expected to close on May 14, 2018, subject to customary closing conditions. Integra intends to use the net proceeds from the offering, including any proceeds received from an exercise of the underwriters’ option to purchase additional shares, to reduce outstanding revolving borrowings under Integra’s senior credit facility. The shares will be issued pursuant to an effective shelf registration statement on Form S-3.
- GlobeNewswire•last month
Integra LifeSciences Announces Proposed Public Offering of Common Stock
Integra LifeSciences Holdings Corporation (IART), a leading global medical technology company, today announced that it intends to offer, subject to market conditions and other factors, 5,250,000 shares of its common stock in an underwritten public offering registered under the Securities Act of 1933, as amended. In connection with the offering, Integra expects to grant the underwriters a 30-day option to purchase an additional 787,500 shares of common stock. Integra intends to use the net proceeds from the offering, including any net proceeds received from an exercise of the underwriters’ option to purchase additional shares, to reduce outstanding revolving borrowings under Integra’s senior credit facility.
- GlobeNewswire•last month
Integra LifeSciences Announces Amendment and Extension of Credit Facility
PLAINSBORO, N.J., May 07, 2018-- Integra LifeSciences Holdings Corporation, a leading global medical technology company, today announced that it has amended and extended its credit facility with a bank ...
- Market Realist•last month
Will Dentsply Sirona Recover from Its Recent Stock Price Lows?
On May 3, Dentsply Sirona (XRAY) closed at $49.24 per share. The stock registered a fall of 2.7% on the day. The stock registered a 52-week low on April 2, when it traded at $48.25. However, it was trading at a 52-week high of $68.98 on November 28, 2017.
Market Realist•2 months agoWill Dentsply Sirona Beat Analysts’ Revenue Estimates in 1Q18?
Dentsply Sirona (XRAY) will announce its 1Q18 results on May 7. The company has recently made some organizational changes and key management changes. It’s also recently announced its acquisition of OraMetrix to expand its orthodontic treatment solutions portfolio.
Market Realist•2 months agoAnalysts Expect a Fall in Dentsply Sirona’s Adjusted Earnings
Dentsply Sirona (XRAY) accounts for ~0.29% of the total holdings of the Vanguard Mid-Cap ETF (VO). The company is set to release its 1Q18 results on May 7.
- GlobeNewswire•2 months ago
Integra LifeSciences to Present at Healthcare Conference in May 2018
PLAINSBORO, N.J., April 26, 2018-- Integra LifeSciences Holdings Corporation, a leading global medical technology company, will present at the following healthcare conferences in May:. On Tuesday, May ...
- Zacks•2 months ago
Integra LifeSciences (IART) Tops on Q1 Earnings, '18 View Up
Integra LifeSciences' (IART) revenue growth was primarily driven by high organic revenues, successful progress with Codman integration and progress with the channel expansion strategy.
- Thomson Reuters StreetEvents•2 months ago
Edited Transcript of IART earnings conference call or presentation 25-Apr-18 12:30pm GMT
Q1 2018 Integra LifeSciences Holdings Corp Earnings Call
- Investor's Business Daily•2 months ago
IPO Leaders Add Jagged Peak Energy To List; See Who Joined Other Stocks To Watch Lists
Here are today’s top growth stocks that have just been added to the IBD stock lists, including the IBD 50, IPO Leaders and the IBD Big Cap 20.
- Investor's Business Daily•2 months ago
Dow Outperforms Thanks To Boeing; Nasdaq Recovers But Growth Stocks Hit Hard
The Nasdaq recovered nicely Wednesday after dropping 1.1% intraday, but several growth stocks, including China names, remained under selling pressure.
- ACCESSWIRE•2 months ago
Integra LifeSciences Holdings Corporation to Host Earnings Call
NEW YORK, NY / ACCESSWIRE / April 25, 2018 / Integra LifeSciences Holdings Corporation (NASDAQ: IART ) will be discussing their earnings results in their Q1 Earnings Call to be held on April 25, 2018 at ...
- Associated Press•2 months ago
Integra: 1Q Earnings Snapshot
On a per-share basis, the Plainsboro, New Jersey-based company said it had net income of 14 cents. Earnings, adjusted for one-time gains and costs, were 58 cents per share. The results beat Wall Street ...
- GlobeNewswire•2 months ago
Integra LifeSciences Reports First Quarter 2018 Financial Results
Revenue Increased 38.1% to $357.1 million; Organic Revenue Increased 3.0%. Reported EPS of $0.14; Adjusted EPS of $0.58. Company Raises Full-Year Total Revenue and EPS Guidance.
- Benzinga•2 months ago
The Week Ahead In Biotech: PDUFA Dates, IPOs And More
The iShares NASDAQ Biotechnology Index (ETF) (NASDAQ: IBB ) is almost flat for the week after adding about 5 percent in the week ended April 13. Will the following catalytic events lead to a resumption ...
- GlobeNewswire•2 months ago
Integra LifeSciences to Host First Quarter 2018 Earnings Results Conference Call on April 25, 2018
PLAINSBORO, N.J., April 11, 2018-- Integra LifeSciences Holdings Corporation, a leading global medical technology company, will release first quarter 2018 financial results on Wednesday, April 25, 2018, ...
Market Realist•2 months agoWill Dentsply Sirona Stock Recover from Recent Declines?
On April 6, 2018, Dentsply Sirona (XRAY) ended at a closing price of $49.02 per share. The stock declined by ~0.14% on the day. XRAY stock was trading at a 52-week high of $68.98 on November 28, 2017. However, the company’s 52-week low came on April 2, 2018, at $48.25. This recent stock price decline was triggered by negative investor sentiments for the company due to recent target price cuts by Wall Street analysts following downward revisions and modelling adjustments in the company’s fiscal 4Q17 earnings release on March 2 and the recent OraMetrix acquisition announcement.
- Zacks•3 months ago
Why Is Integra LifeSciences (IART) Up 3.6% Since Its Last Earnings Report?
Integra LifeSciences (IART) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
